// you’re reading...

General Biotechnology

Big pharma’s pain could be biotech’s gain

By Yali ⋅ October 13, 2004 ⋅ Email This Post Email This Post ⋅ Print This Post Print This Post ⋅ Post a comment

Big pharma’s pain could be biotech’s gain
“Current problems besetting ‘big pharma’ could have a silver lining for the smaller biotechnology sector, some investors believe.”

Print This Post

Discussion

No comments for “Big pharma’s pain could be biotech’s gain”

Post a comment

Building Biotechnology - Starting, Managing, and Understanding Biotechnology Companies   The Business of Biotechnology - Profit From the Growing Influence of Biotechnology
Best Practices in Biotechnology Business Development Best Practices in Biotechnology Education
Journal of Commercial Biotechnology 
DrugPatentWatch.com